Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Species-dependent in vivo mRNA delivery and cellular responses to nanoparticles

Nature Nanotechnology volume 17, pages 310–318 (2022)Cite this article

Subjects

Abstract

Nanoparticles are tested in mice and non-human primates before being selected for clinical trials. Yet the extent to which mRNA delivery, as well as the cellular response to mRNA drug delivery vehicles, is conserved across species in vivo is unknown. Using a species-independent DNA barcoding system, we have compared how 89 lipid nanoparticles deliver mRNA in mice with humanized livers, primatized livers and four controls: mice with ‘murinized’ livers as well as wild-type BL/6, Balb/C and NZB/BlNJ mice. We assessed whether functional delivery results in murine, non-human primate and human hepatocytes can be used to predict delivery in the other species in vivo. By analysing in vivo hepatocytes by RNA sequencing, we identified species-dependent responses to lipid nanoparticles, including mRNA translation and endocytosis. These data support an evidence-based approach to making small-animal preclinical nanoparticle studies more predictive, thereby accelerating the development of RNA therapies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Characterizing SANDS.
Fig. 2: Nanoparticle delivery across murine, NHP and human hepatocytes in vivo.
Fig. 3: Transcriptomic studies reveal species-dependent response to LNPs.
Fig. 4: Inflammatory genes impact mRNA delivery across multiple mouse strains.

Similar content being viewed by others

Data availability

All RNA sequencing data have been deposited online at GEO (GSE178313). The scripts used to analyse barcodes are available at Github (https://github.com/Jack-Feldman/barcode_count). All other data are shown in the figures.

References

  1. Adams, D. et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N. Engl. J. Med. 379, 11–21 (2018).

    Article  CAS  Google Scholar 

  2. Garrelfs, S. F. et al. Lumasiran, an RNAi therapeutic for primary hyperoxaluria type 1. N. Engl. J. Med. 384, 1216–1226 (2021).

    Article  CAS  Google Scholar 

  3. Balwani, M. et al. Phase 3 trial of RNAi therapeutic givosiran for acute intermittent porphyria. N. Engl. J. Med. 382, 2289–2301 (2020).

    Article  CAS  Google Scholar 

  4. Ray, K. K. et al. Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol. N. Engl. J. Med. 382, 1507–1519 (2020).

    Article  CAS  Google Scholar 

  5. Finkel, R. S. et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N. Engl. J. Med. 377, 1723–1732 (2017).

    Article  CAS  Google Scholar 

  6. Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403–416 (2020).

    Article  Google Scholar 

  7. Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603–2615 (2020).

    Article  CAS  Google Scholar 

  8. Sahin, U. et al. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature 547, 222–226 (2017).

    Article  CAS  Google Scholar 

  9. Nair, J. K. et al. Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing. J. Am. Chem. Soc. 136, 16958–16961 (2014).

    Article  CAS  Google Scholar 

  10. Akinc, A. et al. The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs. Nat. Nanotechnol. 14, 1084–1087 (2019).

    Article  CAS  Google Scholar 

  11. Akinc, A. et al. Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. Mol. Ther. 18, 1357–1364 (2010).

    Article  CAS  Google Scholar 

  12. Willoughby, J. L. S. et al. Evaluation of GalNAc-siRNA conjugate activity in pre-clinical animal models with reduced asialoglycoprotein receptor expression. Mol. Ther. 26, 105–114 (2018).

    Article  CAS  Google Scholar 

  13. Lisowski, L. et al. Selection and evaluation of clinically relevant AAV variants in a xenograft liver model. Nature 506, 382–386 (2014).

    Article  CAS  Google Scholar 

  14. Paulk, N. K. et al. Bioengineered AAV capsids with combined high human liver transduction in vivo and unique humoral seroreactivity. Mol. Ther. 26, 289–303 (2018).

    Article  CAS  Google Scholar 

  15. Vercauteren, K. et al. Superior in vivo transduction of human hepatocytes using engineered AAV3 capsid. Mol. Ther. 24, 1042–1049 (2016).

    Article  CAS  Google Scholar 

  16. Pei, X. et al. Development of AAV variants with human hepatocyte tropism and neutralizing antibody escape capacity. Mol. Ther. Methods Clin. Dev. 18, 259–268 (2020).

    Article  CAS  Google Scholar 

  17. Wilson, E. M. et al. Extensive double humanization of both liver and hematopoiesis in FRGN mice. Stem Cell Res. 13, 404–412 (2014).

    Article  CAS  Google Scholar 

  18. Foquet, L. et al. Successful engraftment of human hepatocytes in uPA-SCID and FRG® KO mice. Methods Mol. Biol. 1506, 117–130 (2017).

    Article  CAS  Google Scholar 

  19. Chen, D. et al. Rapid discovery of potent siRNA-containing lipid nanoparticles enabled by controlled microfluidic formulation. J. Am. Chem. Soc. 134, 6948–6951 (2012).

    Article  CAS  Google Scholar 

  20. Sago, C .D. et al. Modifying a commonly expressed endocytic receptor retargets nanoparticles in vivo. Nano Lett. 18, 7590–7600 (2018).

    Article  CAS  Google Scholar 

  21. Sago, C. D. et al. Nanoparticles that deliver RNA to bone marrow identified by in vivo directed evolution. J. Am. Chem. Soc. 140, 17095–17105 (2018).

    Article  CAS  Google Scholar 

  22. Sago, C. D. et al. High-throughput in vivo screen of functional mRNA delivery identifies nanoparticles for endothelial cell gene editing. Proc. Natl Acad. Sci. USA 115, E9944–E9952 (2018).

    Article  CAS  Google Scholar 

  23. Tiwari, P. M. et al. Engineered mRNA-expressed antibodies prevent respiratory syncytial virus infection. Nat. Commun. 9, 3999 (2018).

    Article  Google Scholar 

  24. Paunovska, K. et al. Nanoparticles containing oxidized cholesterol deliver mRNA to the liver microenvironment at clinically relevant doses. Adv. Mater. 31, e1807748 (2019).

    Article  Google Scholar 

  25. Dong, Y. et al. Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates. Proc. Natl Acad. Sci. USA 111, 3955–3960 (2014).

    Article  CAS  Google Scholar 

  26. Dahlman, J. E. et al. In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight. Nat. Nanotechnol. 9, 648–655 (2014).

    Article  CAS  Google Scholar 

  27. Lokugamage, M. P. et al. Mild innate immune activation overrides efficient nanoparticle-mediated RNA delivery. Adv. Mater. 32, 1904905 (2020).

    Article  CAS  Google Scholar 

  28. Paunovska, K. et al. Analyzing 2000 in vivo drug delivery data points reveals cholesterol structure impacts nanoparticle delivery. ACS Nano 12, 8341–8349 (2018).

    Article  CAS  Google Scholar 

  29. Patel, S. et al. Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA. Nat. Commun. 11, 983 (2020).

    Article  CAS  Google Scholar 

  30. Mui, B. L. et al. Influence of polyethylene glycol lipid desorption rates on pharmacokinetics and pharmacodynamics of siRNA lipid nanoparticles. Mol. Ther. Nucleic Acids 2, e139 (2013).

    Article  CAS  Google Scholar 

  31. Kaczmarek, J. C. et al. Optimization of a degradable polymer-lipid nanoparticle for potent systemic delivery of mRNA to the lung endothelium and immune cells. Nano Lett. 18, 6449–6454 (2018).

    Article  CAS  Google Scholar 

  32. Kranz, L. M. et al. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature 534, 396–401 (2016).

    Article  Google Scholar 

  33. Cheng, Q. et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing. Nat. Nanotechnol. 15, 313–320 (2020).

    Article  CAS  Google Scholar 

  34. Lokugamage, M. P., Sago, C. D. & Dahlman, J. E. Testing thousands of nanoparticles in vivo using DNA barcodes. Curr. Opin. Biomed. Eng. 7, 1–8 (2018).

    Article  Google Scholar 

  35. Patel, S. et al. Boosting intracellular delivery of lipid nanoparticle-encapsulated mRNA. Nano Lett. 17, 5711–5718 (2017).

    Article  CAS  Google Scholar 

  36. Picelli, S. et al. Full-length RNA-seq from single cells using Smart-seq2. Nat. Protoc. 9, 171–181 (2014).

    Article  CAS  Google Scholar 

  37. Ge, S. X., Son, E. W. & Yao, R. iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data. BMC Bioinformatics 19, 534 (2018).

    Article  CAS  Google Scholar 

  38. Low, J. Z. B., Khang, T. F. & Tammi, M. T. CORNAS: coverage-dependent RNA-Seq analysis of gene expression data without biological replicates. BMC Bioinformatics 18, 575 (2017).

    Article  Google Scholar 

  39. Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44–57 (2009).

    Article  CAS  Google Scholar 

  40. Szklarczyk, D. et al. The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible. Nucleic Acids Res. 45, D362–D368 (2017).

    Article  CAS  Google Scholar 

  41. Dobrovolskaia, M. A., Shurin, M. & Shvedova, A. A. Current understanding of interactions between nanoparticles and the immune system. Toxicol. Appl. Pharmacol. 299, 78–89 (2016).

    Article  CAS  Google Scholar 

  42. Azuma, H. et al. Robust expansion of human hepatocytes in Fah–/–/Rag2–/–/Il2rg–/– mice. Nat. Biotechnol. 25, 903–910 (2007).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank K. E. Tiegreen, S. Durham and R. Hughley at Georgia Institute of Technology. The work was funded by the National Institutes of Health (R01-GM132985, awarded to J.E.D., and UG3-TR002855, awarded to J.E.D. and P.J.S.) and DARPA (PREPARE, grant no. HR00111920008, awarded to P.J.S. and J.E.D.).

Author information

Author notes

  1. These authors contributed equally: Marine Z.C. Hatit, Melissa P. Lokugamage, Curtis N. Dobrowolski.

Authors and Affiliations

  1. Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA

    Marine Z. C. Hatit, Melissa P. Lokugamage, Curtis N. Dobrowolski, Kalina Paunovska, Huanzhen Ni, Kun Zhao, David Loughrey, Manaka Sato, Ana Cristian, Philip J. Santangelo & James E. Dahlman

  2. Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA, USA

    Daryll Vanover, Jared Beyersdorf, Hannah E. Peck & Philip J. Santangelo

Authors
  1. Marine Z. C. Hatit
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Melissa P. Lokugamage
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Curtis N. Dobrowolski
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kalina Paunovska
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Huanzhen Ni
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kun Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Daryll Vanover
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jared Beyersdorf
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hannah E. Peck
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. David Loughrey
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Manaka Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Ana Cristian
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Philip J. Santangelo
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. James E. Dahlman
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

M.Z.C.H., C.N.D., P.J.S. and J.E.D. conceived the experiments. P.J.S. and J.E.D. obtained funding for, and oversaw, the research. All authors performed the experiments. M.Z.C.H., C.N.D. and J.E.D. wrote the initial manuscript, which was edited by the authors.

Corresponding author

Correspondence to James E. Dahlman.

Ethics declarations

Competing interests

J.E.D. is a consultant for GV. All other authors declare no competing interests.

Peer review

Peer review information

Nature Nanotechnology thanks David Morrissey and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hatit, M.Z.C., Lokugamage, M.P., Dobrowolski, C.N. et al. Species-dependent in vivo mRNA delivery and cellular responses to nanoparticles. Nat. Nanotechnol. 17, 310–318 (2022). https://doi.org/10.1038/s41565-021-01030-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41565-021-01030-y

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research